IGF-1 LR3 (1mg)
$100.00
IGF-1 LR3 is a synthetic peptide analog of human IGF-1, modified to enhance stability in controlled experimental environments. This analog features an arginine substitution at position 3 and an extended amino acid sequence to alter receptor-binding characteristics. Supplied as a lyophilized powder, IGF-1 LR3 is intended exclusively for in vitro laboratory research and analytical applications.
IGF-1 LR3 is a well-characterized synthetic peptide used in laboratory research to study peptide–receptor interactions, ligand binding dynamics, and intracellular signaling pathways. Its defined sequence allows precise evaluation of receptor affinity, structure-function relationships, and stability in controlled experimental conditions. The lyophilized format ensures reproducibility and integrity for non-clinical research studies.
Research Applications
IGF-1 LR3 is suitable for in vitro studies including:
Analysis of insulin-like growth factor receptor (IGF-1R) binding and signaling pathways
Modeling ligand–receptor interactions and affinity characterization
Evaluation of intracellular signaling cascades associated with peptide ligands
Structure-function analysis of modified IGF-1 analogs
Assessment of stability, degradation, and analytical profiling in assay-based systems
Storage and Handling
Store lyophilized powder at -20°C
After reconstitution, maintain at 2–8°C and use promptly
Follow aseptic techniques during laboratory handling
Product Specifications
Purity: ≥99% (HPLC Certified)
Appearance: White lyophilized powder
Solubility: Soluble in appropriate laboratory solvents
Compliance Notice
For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse may violate federal, state, or local laws. By purchasing, the buyer confirms use strictly for in vitro research purposes.
